Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice.
about
Current and future antiviral therapy of severe seasonal and avian influenzaAntibodies against viruses: passive and active immunizationA common solution to group 2 influenza virus neutralizationImmunity to retroviral infection: the Friend virus modelT cell-mediated host immune defenses in the lungNear-infrared laser adjuvant for influenza vaccinePrevention and treatment of influenza with hyperimmune bovine colostrum antibodyProphylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenzaAvian influenza virus (H5N1): a threat to human health.Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine.A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus.Cross-reactive neutralizing antibody against pandemic 2009 H1N1 influenza a virus in intravenous immunoglobulin preparationsBroadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.Early adaptive humoral immune responses and virus clearance in humans recently infected with pandemic 2009 H1N1 influenza virusA human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice.A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infectionmTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cellsPassive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells.Protective role of gamma interferon during the recall response to influenza virus.Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity.Sustained viral load and late death in Rag2-/- mice after influenza A virus infection.Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virusIncreased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutantsCompromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice.The role of neutralizing antibodies for mouse mammary tumor virus transmission and mammary cancer development.High mutant frequency in populations of a DNA virus allows evasion from antibody therapy in an immunodeficient hostTowards a novel influenza vaccine: engineering of hemagglutinin on a platform of adenovirus dodecahedron.Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production.Role of B cells in maintaining helper T-cell memorySpecificity and Effector Functions of Human RSV-Specific IgG from Bovine Milk.Use of pre-S protein-containing hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for chronic hepatitis B virus infection.Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection.Modulation of the immune response to respiratory viruses by vitamin D.Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutininCirculating immunoglobulin G can play a critical role in clearance of intestinal reovirus infection.
P2860
Q24656164-0120D731-90FB-461D-9729-167594EE1C15Q27489392-6BAFF2EA-981D-41A8-864D-12EF21B978E1Q27680873-C9D78020-65FF-410A-9D8B-35061B8B6576Q28243606-B2165878-B223-4209-B12C-88A0511C6A34Q28395374-0BA9BCFD-821F-42AB-8461-C461E3A3FA1BQ28536886-04F632FB-6460-4318-8E4A-F3547E73F370Q28748705-D2F080D3-3D21-4043-9F73-362D323C573BQ28757651-096FB4C0-EE28-497D-8D44-01D6831B9EBBQ30361041-37253C1A-1ACE-4A57-AF00-694B24F98896Q30378572-0F11EE99-D836-48A9-8CC3-E59E42BD846DQ30386068-CFC4977D-EB47-4286-8030-F87CC20CE1E7Q30388405-D52028D1-860F-4335-8CD9-718AC1BD6CA5Q30392802-3D6AEE6F-DBA4-4A5B-80CE-107D1F219264Q30398435-118D08F8-175A-4537-B34E-CE0441F2650CQ30406631-56246FC7-EB06-4F26-945F-5FB06F3D7C1BQ30411637-DCE86E4E-55C3-41DC-8598-54F8BD77AB32Q30442822-52FAD072-7832-4CBF-B07E-EABB60E6B0D7Q33577691-8F54CD95-0A4C-4381-80C4-8C54CB6027A3Q33609242-997A04D8-0E1C-45C8-AF65-95439040B289Q33778686-E0FCAA0F-2B1C-4E32-B2D6-23FFBE508040Q33782214-90B2A5EE-364D-48CC-B95A-49D371A1D926Q33783554-5ED98184-93AA-4DB6-8371-FF4AEB60C5FCQ33788879-EC3107B6-E670-478B-86C0-A8826D9797FFQ33836053-7B6732C8-5A83-4388-A34E-04102BF9C38FQ33979910-49ED2401-0FB1-4BA9-AD47-6EF4799D8C21Q34057331-E4D8E7CE-4901-4FBE-9C58-26464FBC77C1Q34070021-E1979F77-95F5-45FA-A1FD-00E7A0B0E565Q34327111-2EAC1697-95D4-4D34-BF96-1C35B65DFDBCQ34359535-2F745D9E-8041-41B6-9955-58176160968EQ34467281-1247ECDE-13A8-49AB-8526-16475CECD8D3Q34472287-4275F886-E708-4D10-BAB2-E32980302E7AQ34773596-94C4C547-29C6-44A4-AE5E-63C640C19B78Q34819672-81BFF557-82FD-4107-B753-2DA0C37ACE4BQ35212655-73CBE74C-A8E2-4790-AF64-783DD0E1D5F5Q35399929-0CFAF43A-EDE1-44FB-B175-49D5EEC2A007Q35739131-810CA126-B817-4AE5-99DA-6415B4E25508Q35786912-5D15C392-5C51-4378-ADA4-79285F3EE926Q35808859-8C4C6460-CF46-42FA-A07D-F7651D51A9D8Q35852069-9C99DD53-766F-4D15-973D-B59FBA25E491Q35854941-45F31707-E8C8-4FCF-A054-390BBD53AFCF
P2860
Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Virus-neutralizing antibodies ...... virus pneumonia in SCID mice.
@ast
Virus-neutralizing antibodies ...... virus pneumonia in SCID mice.
@en
type
label
Virus-neutralizing antibodies ...... virus pneumonia in SCID mice.
@ast
Virus-neutralizing antibodies ...... virus pneumonia in SCID mice.
@en
prefLabel
Virus-neutralizing antibodies ...... virus pneumonia in SCID mice.
@ast
Virus-neutralizing antibodies ...... virus pneumonia in SCID mice.
@en
P2093
P2860
P1433
P1476
Virus-neutralizing antibodies ...... virus pneumonia in SCID mice.
@en
P2093
G Palladino
K Mozdzanowska
P2860
P304
P407
P577
1995-04-01T00:00:00Z